Unicycive Therapeutics, Inc. (UNCY)
6.56
+0.37
(+5.98%)
USD |
NASDAQ |
Jan 20, 13:05
Unicycive Therapeutics EPS Diluted (Quarterly): -0.3327 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avantor, Inc. | -1.044 |
| Treace Medical Concepts, Inc. | -0.2564 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.011M |
| Total Expenses (Quarterly) | 6.011M |
| Enterprise Value | 90.60M |
| Earnings Yield | -42.65% |
| Normalized Earnings Yield | -32.55 |